HR Path Strengthens SAP SuccessFactors Expertise as tts digital HR experts Joins the Group HR Path, a global leader in Human Resources, announces the acquisition of… CISION PRNewswireSeptember 9, 2026
Press ReleaseBEYOND THE CANVAS: JEFF KOONS REIMAGINES TIME WITH HUBLOT NYON, Switzerland, Sept. 9, 2026 /PRNewswire/ — Hublot proudly announces an extraordinary… CISION PRNewswireSeptember 9, 2026
Daesang Targets Global Pharmaceutical Amino Acid Market, Building on 70 Years of Fermentation Technology Leverages fermentation know-how developed through MIWON to expand beyond general-purpose amino acids… CISION PRNewswireSeptember 9, 2026
Press ReleaseDJI Hosts Filmmakers & Visionaries Session at Venice Production Bridge During the 83rd Venice International Film Festival New Generation, New Cinematic Language: Osmo Pocket 4P Sparks a New Conversation… CISION PRNewswireSeptember 9, 2026
Transcenta Therapeutics and WuXi Biologics Enter into Strategic Collaboration to Accelerate Commercialization of HiCB Continuous Bioprocessing Technologies PRINCETON, N.J. and SUZHOU, China, Sept. 9, 2026 /PRNewswire/ — Transcenta Therapeutics (HKEX:… CISION PRNewswireSeptember 9, 2026
Press ReleaseMobinet to Deploy Plume Platform for Delivery of Smarter WiFi, Enhanced Security and Better Customer Experience to Subscribers across Mongolia New AI-powered mobihome service gives customers stronger WiFi, advanced protection and greater… CISION PRNewswireSeptember 9, 2026
Kazia Therapeutics Announces First Patient Dosed in PNOC035 Clinical Study Evaluating Paxalisib for Recurrent Pediatric AT/RT Brain Cancer Multicenter study to evaluate paxalisib plus gemcitabine for children and young adults… CISION PRNewswireSeptember 9, 2026
Harbour BioMed Partner, Solstice Oncology, announces $225 Million Series A Financing to Advance Porustobart, a Neoadjuvant Immuno-Oncology Therapy Porustobart, a second-generation Fc-enhanced CTLA-4 antibody, is being advanced across two clinical… CISION PRNewswireSeptember 9, 2026
